标识符 | 资源中文名称 | 资源英文名称 | 疾病概述 | 制作方法 | 相关文章 |
---|---|---|---|---|---|
CSTR:16397.09.0G01000501 | 叉头基因FOXP3敲除小鼠 | C.Cg-foxp3tm2 | X连锁的淋巴细胞增殖性疾病 |
敲除小鼠 |
ChenZ; Herman AE; Matos M; Mathis D; Benoist C. 2005. Where CD4+CD25+T reg cells impinge on autoimmune diabetes. J Exp Med 202(10): 1387-97. |
CSTR:16397.09.0H01000499 | Drd5基因敲除小鼠 | B6.129P2-Drd5tm1 | 心肌病 |
基因敲除 |
|
CSTR:16397.09.0G01000498 | Nfkb1基因敲除小鼠 | B6;129P-Nfkb1tm1 | 免疫缺陷 |
||
CSTR:16397.09.0A01000497 | SOD1基因敲除小鼠 | B6;129S7-Sod1tm1 | 视网膜功能障碍和家族性肌萎缩性侧索硬化症(ALS)等。 |
基因敲除 |
|
CSTR:16397.09.0F01000496 | Fat自发突变小鼠 | B6.HRS(BKS)-Cpefat | 糖尿病 |
自发突变 |
|
CSTR:16397.09.0F01000495 | 内脂素转基因小鼠 | C57BL/6J--TgN(Visfatin)ZLFILAS | 脂代谢相关疾病 |
|
1.Fantuzzi G. Adipose tissue, adipokines, and inflammation [J]. J Allergy Clin Immunol, 2005, 115: 911-919. 2. OgnjanovicC, Bryant-Greenwood GD. Pre-B cell colony-enhancing factor, a novel cytokine of human fetal membranes[J]. Am J Obstet Gynecol, 2002, 187(4): 1051-1058. |
CSTR:16397.09.0F01000493 | APOE基因敲除小鼠 | B6.129P2.APOE |
脂代谢相关疾病 |
基因敲除,破坏第四外显子 |
|
CSTR:16397.09.0F01000492 | 24-脱氢胆固醇还原酶基因转基因小鼠 | C57BL/6J--TgN(CMV-Dhcr24)-ILAS | 脂代谢相关疾病 |
CMV全身性启动子启动的Dhcr24转基因小鼠 |
|
CSTR:16397.09.0A01000491 | I型胶原蛋白基因点突变大鼠 | SD. COL1A1 (TM-C.T149G) -GC/ILAS | 成骨不全(Osteogenesisimperfecta,OI)是一种由于Ⅰ型胶原形成障碍,导致骨脆性增强为主要症状的 常染色体显性遗传性疾病。临床上主要表现为骨质脆弱、蓝巩膜、耳聋和中等程度的关节畸形等症状。 |
利用Crispr/cas9技术制备COL1A1点突变大鼠,突变位点为C.T149G。 |
|
CSTR:16397.09.0L01000654 | Cdkn1a 基因敲除小鼠 | B6;129S2-Cdkn1atm1 | 肿瘤相关 |
基因敲除 |
1Brugarolas J; Chandrasekaran C; Gordon JI; Beach D; Jacks T; Hannon GJ. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377(6549):552-7. 2Carstens MJ; Krempler A; Triplett AA; Van Lohuizen M; Wagner KU. 2004. Cell cycle arrest and cell death are controlled by p53-dependent and p53-independent mechanisms in Tsg101-deficient cells. J Biol Chem 279(34):35984-94. |
CSTR:16397.09.0I01000653 | Alox15 敲除小鼠 | B6.129S2-Alox15tm1 | 血液病 |
基因敲除小鼠,破坏第三外显子。 |
1Middleton MK; Zukas AM; Rubinstein T; Jacob M; Zhu P; Zhao L; Blair I; Pure E. 2006. Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease. J Exp Med 203(11):2529-40. 2Sun D; Funk CD. 1996. Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J Biol Chem 271(39):24055-62. Additional References |
CSTR:16397.09.0G01000652 | Mapk9 敲除小鼠 | B6.129S2-Mapk9tm1 | 信号转导相关 |
基因敲除 |
1Yang DD; Conze D; Whitmarsh AJ; Barrett T; Davis RJ; Rincon M; Flavell RA. 1998. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9(4):575-85. 2Abdelli S; Puyal J; Bielmann C; Buchillier V; Abderrahmani A; Clarke PG; Beckmann JS; Bonny C. 2009. JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis. Diabetologia 52(9):1871-80. |